Jefferies raises Abbott Labs stock price target to $146 on medical device growth
PositiveFinancial Markets

Jefferies has raised its price target for Abbott Labs to $146, highlighting the company's strong growth in the medical device sector. This adjustment reflects confidence in Abbott's innovative products and their potential to capture a larger market share, which is great news for investors looking for promising opportunities in healthcare.
— Curated by the World Pulse Now AI Editorial System